Skip to content

Subthreshold micropulse laser in macular oedema after Pars PLana Vitrectomy

Subthreshold micropulse laser in macular oedema after Pars PLana Vitrectomy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080666
Enrollment
Unknown
Registered
2024-02-04
Start date
2024-02-05
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic macula edema

Interventions

Subthreshold micropulse laser group:Subthreshold micropulse laser
Vitreous cavity injection of anti-VEGF drug group:Vitreous cavity injection of anti-VEGF drugs

Sponsors

The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old; 2. Patients who underwent vitrectomy for PDR at our hospital; 3. At least 1 optical coherence tomography (OCT) scan within 3 months after vitrectomy suggesting macular edema, i.e., CRT = 300 µm and/or subretinal fluid and/or intraretinal fluid within 500 µm of the center of the macula with a CRT 0.05 (decimalized); 5. Consent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Combined retinal vein occlusion, uveitis, ocular trauma, age-related macular degeneration or other ocular or systemic conditions that may cause macular edema: 2. Have received vitreous cavity drug injections after vitrectomy or postoperatively ; 3. re-supplemental retinal laser photocoagulation after vitrectomy; 4. silicone oil filled eyes; 5. Re-vitrectomy; 6. follow-up for less than 6 months; 7. women during pregnancy or lactation; 8. Those who cannot cooperate due to major systemic diseases such as stroke, cardiovascular and cerebrovascular accidents or other reasons

Design outcomes

Primary

MeasureTime frame
central retinal thickness;best-corrected visual acuity;number of treatments with sub-threshold micropulse laser group;number of treatments in the vitreous cavity injection of anti-VEGF drug group;

Secondary

MeasureTime frame
morphological structure of macular OCT;microvision;adverse events during follow-up;

Countries

China

Contacts

Public ContactLin Zhong

The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University

linzhong_@126.com+86 137 5847 5525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026